Funds and ETFs Nanosonics Limited

Equities

NAN

AU000000NAN9

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:38 2024-05-17 am EDT 5-day change 1st Jan Change
2.82 AUD -6.31% Intraday chart for Nanosonics Limited -3.09% -35.91%

ETFs positioned on Nanosonics Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 746 M€ -.--% -
0.00% 10 M€ -3.35% -
0.00% 34 M€ +3.87% -
Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon EPR. The Company's trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics AuditPro is an automated digital system that combines clinician infection prevention decision making, with the Trophon 2 device infection control workflow data, and patient procedure information.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2.82 AUD
Average target price
3.204 AUD
Spread / Average Target
+13.62%
Consensus
  1. Stock Market
  2. Equities
  3. NAN Stock
  4. Funds and ETFs Nanosonics Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW